All images in this section are for illustration purposes only. Not actual patients or caregivers.

XEOMIN Dosing for Chronic Sialorrhea in Pediatric Patients

Dosing Sites Focus on 2 Key Glands1

*No dosing recommendations for children <12 kg.

  • Recommended dose: based on body weight administered in a 3:2 dose ratio into the parotid and submandibular glands, respectively, no sooner than every 16 weeks1
XEOMIN is the first and only FDA-approved neuromodulator
for pediatric patients with chronic sialorrhea


  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2021.